Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial
This study was supported by grants from the National Natural Science Foundation of China (82373213 to Dr Gao, 82202952 to Dr Wang); and the Natural Science Foundation of Guangdong Province (2023A1515010290 to Dr Chang). Funding sources were not involved in the study design, data collection, analysis and interpretation, writing of the report, or decision to submit the article for publication.
Authors
- Xue Tian (ORCID: https://orcid.org/0000-0001-9164-3631)
- Jiang Wu (ORCID: https://orcid.org/0000-0002-8603-7642)
- Qiaoxuan Wang
- Xiaojun Wu (ORCID: https://orcid.org/0000-0001-8737-6286)
- Weiwei Xiao (ORCID: https://orcid.org/0000-0002-9922-640X)
- Yuanhong Gao (ORCID: https://orcid.org/0000-0002-6429-5376)
- Zi-Tong Zhang
- Rong Zhang (ORCID: https://orcid.org/0000-0003-1188-0640)
- Li Li (ORCID: https://orcid.org/0009-0003-4636-9487)
- Zhi-Zhong Pan
- Hui Chang (ORCID: https://orcid.org/0000-0001-6651-5101)
- Rong-Xin Zhang
- Jun-Zhong Lin
- Wen-Hua Fan
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1016/j.eclinm.2024.102836
- Citations
- 9
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.54
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province